Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
UBS
Colorcon
Chinese Patent Office
Moodys
Cerilliant
Farmers Insurance
Queensland Health

Generated: November 21, 2018

DrugPatentWatch Database Preview

ACAMPROSATE CALCIUM Drug Profile

« Back to Dashboard

When do Acamprosate Calcium patents expire, and when can generic versions of Acamprosate Calcium launch?

Acamprosate Calcium is a drug marketed by Barr Labs Div Teva, Glenmark Generics, Mylan Pharms Inc, and Zydus Pharms Usa Inc. and is included in four NDAs.

The generic ingredient in ACAMPROSATE CALCIUM is acamprosate calcium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.

Drug patent expirations by year for ACAMPROSATE CALCIUM
Synonyms for ACAMPROSATE CALCIUM
1-Propanesulfonic acid, 3-(acetylamino)-, calcium salt (2:1)
1-Propanesulfonic acid, 3-(acetylamino)-, calcium salt (2:1)
2C5H10NO4S.Ca
3-(Acetylamino)-1-propanesulfonic Acid Calcium Salt
3-(Acetylamino)-1-propanesulfonic acid calcium salt (2:1)
3-(Acetylamino)-1-propanesulfonic acid hemicalcium salt
3-Acetamido-1-propanesulfonic Acid Calcium Salt
59375N1D0U
77337-73-6
77337-76-9 (Parent)
AB0017521
AB07649
AC-5599
AC1L4EA7
Acamprosate calcium (JAN/USAN)
Acamprosate calcium [USAN]
Acamprosate calcium salt
ACAMPROSATE CALCIUMSALT
Acamprosatecalcium
AK157058
AKOS015895192
Alcomed
AM032679
AN-6714
ANW-41555
Aotal
API0001351
C-21717
C10H20CaN2O8S2
Calcium 3-(acetylamino)propane-1-sulfonate
Calcium 3-(acetylamino)propanesulphonate
Calcium 3-Acetamido-1-propanesulfonate
calcium 3-acetamidopropane-1-sulfonate
Calcium acamprosate
calcium bis(3-acetamidopropane-1-sulfonate)
CALCIUM BIS(ACAMPROSATE(1-))
Calcium bisacetyl homotaurine
Calcium N-acetylhomotaurinate
Calcium(2+) 3-(acetylamino)propanesulphonate
Campral (TN)
Campral EC
CAMPRAL EC (CALCIUM)
CAS-77337-73-6
CC-23625
CCG-213526
CHEBI:51042
CHEMBL2068724
CTK8B2992
D02780
DR002347
DSSTox_CID_27529
DSSTox_GSID_47529
DSSTox_RID_82399
DTXSID6047529
EINECS 278-665-3
FT-0621712
HMS3264J11
I06-0328
J10409
KM1845
KS-5292
LS-120941
MolPort-003-666-799
N-acetylhomotaurine, calcium (2:1) salt
NCGC00167462-01
NCGC00256899-01
NSC-759186
NSC759186
Pharmakon1600-01505711
Q327
Regtect (TN)
SCHEMBL137771
Sobriol
Tox21_112466
Tox21_302606
UNII-59375N1D0U
Z1696861853

US Patents and Regulatory Information for ACAMPROSATE CALCIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Barr Labs Div Teva ACAMPROSATE CALCIUM acamprosate calcium TABLET, DELAYED RELEASE;ORAL 200143-001 Nov 18, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Zydus Pharms Usa Inc ACAMPROSATE CALCIUM acamprosate calcium TABLET, DELAYED RELEASE;ORAL 205995-001 May 26, 2017 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glenmark Generics ACAMPROSATE CALCIUM acamprosate calcium TABLET, DELAYED RELEASE;ORAL 202229-001 Jul 16, 2013 AB RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc ACAMPROSATE CALCIUM acamprosate calcium TABLET, DELAYED RELEASE;ORAL 200142-001 Mar 11, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fish and Richardson
UBS
Colorcon
Chinese Patent Office
Moodys
Cerilliant
Farmers Insurance
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.